An Early Phase 1 interventional study of Betamethason Sodium Phosphate in Chronic Non Bacterial Prostatitis, sponsored by Cairo University. Status unknown. Open to male participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2019-12-26.
Sponsored by Cairo University · Early Phase 1, Interventional, and Treatment
TRUS guided injection of long acting corticosteroids in chronic non bacterial prostatitis patients who failed to response to medical treamtment
chronic non bacterial prostatitis is usually due to congestion combined with severe inflammatory process of the prostate, it is usually a recurrent bothersome problem, so patients who fail to response to classic medical treatment are expected to benefit from a strong anti inflammatory injection like betamethasone, which has strong anti inflammatory plus anti oedematous properties so limitation of this inflammatory process across the prostate is expected to relieve the patients symptoms
88 studies on the registry are indexed under Prostatitis; 11 are open to participants now.
This study's planned enrollment of 20 is below the median of 60 across 73 interventional studies indexed under Prostatitis.
Browse Prostatitis studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Betamethason Sodium Phosphate
Injection of betamethasone in chronic non bacterial prostatitis patients using Trans rectal Ultrasound
Comparing IPSS before and after injection.
Questionnaire comparing IPSS (international prostatic symptom score) before and after injection
Time frame: evaluation over 3 months after injection
No study locations are listed for this record.
Start is estimated for Jul 2020; primary completion for Jul 2021, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Betamethasone sodium phosphate